GILEAD SCIENCES, INC. — Director's Dealing 2014

Sep 24, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-09-22

Reporting Person: Cogan John Francis (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-22	Common Stock	M	5000	$14.3375	Acquired	47405	Direct
2014-09-22	Common Stock	S	1896	$105.7606	Disposed	45509	Direct
2014-09-22	Common Stock	S	1303	$106.5957	Disposed	44206	Direct
2014-09-22	Common Stock	S	1801	$107.4795	Disposed	42405	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-22	Non-Qualified Stock Option (Right to Buy)	$14.3375	M	5000	Disposed	2016-05-10	Common Stock (5000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Options are 100% vested on the date of grant.

F3: Sale prices reported for the transactions reported here range from $105.31 to $106.28. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $106.31 to $107.25. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: Sale prices reported for the transactions reported here range from $107.31 to $107.54. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.